CM Life Sciences, Inc., Sponsored by Affiliates of Casdin Capital and Corvex Management, Announces Pricing of Upsized $385 Million Initial Public Offering

New York, NY, September 1 2020 (Business Wire) — CM Life Sciences, Inc. (the “Company”) announced today that it priced its initial public offering of 38,500,000 units at $10.00 per unit. The units will be listed on The Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “CMLFU” beginning September 2, 2020.

What do you think?

Written by hsandm

Galectin Therapeutics Appoints Joel Lewis as Chief Executive Officer

Gilead commits $120M with $685M in future potential to Jounce